Aprila

Apremilast INN

Composition :

Aprila-10 Tablet: Each Film Coated Tablet Contains Apremilast INN 10 mg.

Aprila Tablet: Each Film Coated Tablet Contains Apremilast INN 30 mg.

Indications : Apremilast is indicated for the treatment of adult patients with active psoriatic arthritis and patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.

Dosage and administration : Asthma

To reduce risk of gastrointestinal symptoms, titrate to recommended

dose of 30 mg twice daily starting on day 6 according to the following 5 day titration schedule :

Day 1: 10 mg in morning.

· Day 2: 10 mg in morning and 10 mg in evening.

· Day 3: 10 mg in morning and 20 mg in evening.

· Day 4: 20 mg in morning and 20 mg in evening.

· Day 5: 20 mg in morning and 30 mg in evening.

· Day 6 and thereafter: 30 mg twice daily.

Dosage in Severe Renal Impairment: Recommended dose is 30 mg once daily.

Or, as directed by the registered physician.

Use in Pregnancy and lactation : Pregnancy category C. There are no adequate and wellcontrolled studies in pregnant woman. This product should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known whether this medicine is excreted in human milk. Caution should be exercised when this product is administered to a nursing woman.

Packing : Aprila-10 Tablet: Each box contains 1x14's tablets in blister pack.

Aprila Tablet: Each box contains 1x14's tablets in blister pack.

Prescribing Description

Related Products

© Copyright Drug International Ltd. 2019 Designed and Developed by ATI Limited.